AirNexis Therapeutics, Inc. funding
AirNexis Therapeutics, Inc., a biotechnology company based in Palo Alto, CA (founded 2024), filed a Form D with the SEC on March 9, 2026 and reported $62M raised of a $200M offering.
Amount raised$62M
Offering size$200M
Filed with the SECMarch 9, 2026
First saleJanuary 9, 2026
IndustryBiotechnology
SecuritiesEquity
LocationPalo Alto, CA
Founded2024
Entity typeCorporation
Investors so far13
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 9
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology